Is Biotron Ltd halal to invest in?

According to Musaffa's Shariah screening methodology, Biotron Ltd (BIT.AX) is currently classified as HALAL as of February 2026. The classification is based on an evaluation of the company's business activities and financial ratios to determine whether it meets Islamic investment guidelines.

Is Biotron Ltd a Shariah-compliant stock?

A stock is Shariah-compliant if the company operates in permissible business activities and meets Islamic financial screening thresholds. Musaffa analyzes Biotron Ltd using these criteria to determine its compliance status.

Can Muslims buy shares of Biotron Ltd?

Muslim investors may consider investing in Biotron Ltd if it meets Shariah compliance standards. Investors typically review the company's business activities, debt levels, and non-permissible income before making a decision.

Why is Biotron Ltd classified as HALAL?

Musaffa determines the Shariah status of Biotron Ltd by analyzing whether the company's core business operations are permissible and whether its financial ratios fall within accepted Islamic thresholds.

How often is the Shariah compliance for Biotron Ltd updated?

The Shariah compliance status of Biotron Ltd may be updated periodically when new financial statements, earnings reports, or business activity information become available.

Can a halal stock like Biotron Ltd become non-compliant?

Yes. A stock that is currently Shariah-compliant may become non-compliant if the company's financial ratios exceed Shariah thresholds or its business activities change.

Where can I check the Shariah status of Biotron Ltd?

You can check the latest Shariah compliance status of Biotron Ltd on Musaffa's stock page, where screening results and key financial indicators are updated to help Muslim investors make informed decisions.

BIT.AX Shariah Compliance

Screening Methodology: AAOIFI

HALAL

Last Updated: February 10, 2026

Report Source: 2025 Annual Report

Biotron Ltd. Stock Analysis BIT.AX

Australia Health Care Nano Cap Report: 2025 Annual

Biotron Ltd. engages in the funding and management of research, development, and commercialization of drugs targeting significant viral diseases. The company is headquartered in Sydney, New South Wales. The company went IPO on 2001-01-24. The firm is engaged in developing and commercializing a novel small molecule approach that has the potential to treat several serious viral diseases. Its proprietary primary bacterial cell-based screening platform enables rapid screening for target viroporin proteins, including hepatitis C, HIV-1, Dengue, Zika, Influenza, and Respiratory Syncytial Virus (RSV). The firm has developed a library of over 350 compounds with potential activity against a range of viral diseases. Its lead compound, BIT225, is in Phase II development for the treatment of HIV-1. BIT225 appears to inhibit HIV-1 replication in macrophage reservoir cells offering the potential, when used in combination with other anti-retroviral compounds, to eradicate HIV-1. The firm also owns SedRx, which is a general anesthetic containing alfaxalone.

Key Statistics of Biotron Ltd (BIT.AX)

Key statistics in the stock market are essential financial indicators that measure a company's performance, valuation, profitability, and risk.

Today's Range

AUD0.00AUD0.00

Today's Open

AUD0.00

Volume

366.69K

P/E Ratio (TTM)

52 Week Range

AUD0.00AUD0.01

Market Cap

6.75M

Avg. Volume

668.25K

Dividend Yield

Financial Metrics & Statements of Biotron Ltd (BIT.AX)

FAQ's for Biotron Ltd (BIT.AX)

According to Musaffa’s Shariah screening methodology, Biotron Ltd (BIT.AX) is currently classified as HALAL as of February 2026. The classification is based on an evaluation of the company’s business activities and financial ratios to determine whether it meets Islamic investment guidelines.